Novo Nordisk
Healthcare

Novo Nordisk (NYSE: NVO) Stock Tumbles as Zepbound Outperforms Wegovy in Weight Loss Trial

/

Shares of Novo Nordisk (NYSE: NVO) fell more than 3% in pre-market trading Monday after Eli Lilly’s Zepbound outperformed Wegovy […]

Novo Nordisk (NYSE: NVO) Stock Tumbles as Zepbound Outperforms Wegovy in Weight Loss Trial Read More »